Cáncer de Cérvix y virus del papiloma humano. Diagnóstico y prevención.
Authors:
- María Fernanda Calderón LeónMLMaría Fernanda Calderón León
- Ana María Vélez AstudilloAAAna María Vélez Astudillo
- Christian David Verdy MartínezCMChristian David Verdy Martínez
- Francisca Narcisa Briones MoreiraFMFrancisca Narcisa Briones Moreira
- Germania Elizabeth Yugcha AndinoGAGermania Elizabeth Yugcha Andino
- María Luisa Arias LoyolaMLMaría Luisa Arias Loyola
- Raúl Clemente Quintana OrtegaRORaúl Clemente Quintana Ortega
- Darwin Javier Jácome VillacisDVDarwin Javier Jácome Villacis
- José Manuel Vélez MacíasJMJosé Manuel Vélez Macías
- Nataly del Carmen Quisiguiña JarrinNJNataly del Carmen Quisiguiña Jarrin
- Paula Andrea Vasquez JaramilloPJPaula Andrea Vasquez Jaramillo
Open Access
- 1 April 2023
- journal article
- research article
- Published by Universidad Tecnica de Ambato - Carrera de Medicina in Mediciencias UTA
- Vol. 7 (2) , 2-8
Abstract
Introduction: According to global statistics, cervical cancer ranks third among the most common neoplasms affecting women, is considered a public health problem, whose most important risk factor is human papillomavirus (HPV) infection. Objective: The objective of this work is to conduct a review of the literature on Cervical Cancer and human papillomavirus, diagnosis and prevention. Materials and methods: a descriptive, retrospective study, review of scientific medical articles, MedLine databases were consulted , Willey online library, Epistemonikos , PUBMED, ELSEVIER, articles mostly from 2018 onwards, in English and Spanish. Results: The World Health Organization (WHO) has employed strategies to increase HPV vaccination, approved by the US Food and Drug Administration; for all 9- to 45-year-olds, in the prevention of genital, cervical, anal, oropharyngeal, and genital cancers, the American Academy of Pediatrics also recommends vaccinating children before sexual activity between the ages of 11 and 12, having a great collective impact the vaccination of men and women. Currently, cervical diagnosis of HPV is performed with the molecular HPV DNA screening test by PCR, which is the only one approved by the FDA (Food and Drug Administration) of the United States of America, despite the Pap test, despite being a great screening tool for the detection of precancerous and cancerous lesions, it does not detect the HPV virus, but the cytological changes produced by the infection. Conclusion: Human papillomavirus infection is the main cause of cervical cancer. The importance of this research lies in the need to raise awareness for the early screening of the aforementioned virus, in addition to prevention through vaccination, which reduces the incidence of cancer, so that strategies should be implemented, to increase the availability of vaccines, at lower cost, and to inform the population about the benefit of their use, by conducting global awareness campaigns. Keywords: Cervical Dysplasia, Cervical Intraepithelial Neoplasia, Squamous Cervical Intraepithelial Lesions, HPV-16, HPV-18Keywords
This publication has 17 references indexed in Scilit:
- 2020 list of human papillomavirus assays suitable for primary cervical cancer screeningClinical Microbiology and Infection, 2021
- Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillanceOral Oncology, 2021
- WHO Launches Global Push to Eliminate Cervical CancerJAMA, 2021
- HPV post-infection microenvironment and cervical cancerCancer Letters, 2021
- Human papillomavirus vaccine against cervical cancer: Opportunity and challengeCancer Letters, 2020
- The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implicationsCancer Medicine, 2018
- Cervical cancer: A global health crisisCancer, 2017
- Estimation of heritability for nine common cancers using data from genome‐wide association studies in Chinese populationInternational Journal of Cancer, 2016
- Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkersEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Human papillomavirus and cervical cancerThe Lancet, 2013